Watch for drugs that can cause or worsen heart failureNew AHA statement identifies potentially problematic drugs and provides tips for minimizing polypharmacy. Upsurge in ER visits for hypertensionInadequate patient information about interpreting home BP monitor readings may be a contributing factor. Hydroxyzine increases risk of QT prolongation/torsade de pointes in some patients Health Canada reduces maximum daily oral doses and issues new contraindications. Air pollution: Bad for the heart, bad for the fetus New studies provide more data on adverse effects of particulate matter Praxbind: first antidote for a direct-acting oral anticoagulant soon to be marketed Rapidly reverses the effects of dabigatran (Pradaxa) only. Primary prevention of cardiovascular events in older adults Statin therapy and blood pressure control have best evidence for primary prevention of cardiovascular events. Halifax team compares treatment options for ventricular tachycardia Fasting not required for routine lipid profile tests Most lipid levels differ minimally when performed fasting or nonfasting. Device improves function in heart failure patients New HOPE for primary prevention First Previous 38 39 40 41 42 Next Last
